scispace - formally typeset
Open AccessJournal ArticleDOI

Hypercalcemia and cancer: Differential diagnosis and treatment.

TLDR
The initial workup, differential diagnoses, confirmatory laboratory testing, imaging, and medical and surgical management of hypercalcemia are described in the patient with cancer.
Abstract
Incidentally detected hypercalcemia usually presents in an indolent manner and is most likely caused by primary hyperparathyroidism. In contrast, hypercalcemia in the patient with a history of cancer presents in a wide range of clinical settings and may be severe enough to warrant hospitalization. This form of hypercalcemia is usually secondary to hypercalcemia of malignancy and can be fatal. Hypercalcemia of malignancy is most commonly mediated by tumoral production of parathyroid hormone-related protein or by cytokines activating osteoclast degradation of bone. The initial workup, differential diagnoses, confirmatory laboratory testing, imaging, and medical and surgical management of hypercalcemia are described in the patient with cancer.

read more

Citations
More filters
Journal ArticleDOI

[Hypercalcemia - Diagnosis and Management].

M. Koster, +1 more
- 01 Sep 2022 - 
TL;DR: The therapeutic procedure is based on the aetiology and severity of the hypercalcemia, and an accurate measurement of serum calcium in correlation with the parathyroid hormone level is therefore essential.
Journal ArticleDOI

Malignancy-related Hypercalcemia Caused by Metameric Cutaneous Metastasis of Parathyroid Hormone-related Protein-producing Bladder Carcinoma with Squamous Cell Differentiation: An Autopsy Case of Cobb Syndrome.

TL;DR: A 74-year-old woman was admitted with hypercalcemia and prolonged disturbance of consciousness. Based on autopsy findings, a very rare case of Cobb syndrome was diagnosed due to a spinal vascular malformation at the Th12-L4 level and L5 vertebral hemangioma as discussed by the authors .
Journal ArticleDOI

Multidisciplinary Treatment of Liver Metastases from Intracranial SFTs/HPCs: A Report of Three Consecutive Cases

TL;DR: In this article , the authors present their experience in the management of patients with liver metastases from intracranial SFTs/HCPs from January 2014 to December 2020.
Journal ArticleDOI

A Rare Cause of Hypercalcemia

TL;DR: A rare cause of hypercalcemia is Sarcoidosis, which is in most cases caused by primary hyperparathyroidism or a malignant tumor as mentioned in this paper, and therapy with systemic corticosteroids is indicated.
Journal ArticleDOI

Calcium Phosphate Cements as Carriers of Functional Substances for the Treatment of Bone Tissue

TL;DR: In this article , the authors present a review of existing approaches to the production of calcium phosphate cements as drugs and present a description of the pathogenesis of the main diseases of bone tissue (trauma, osteomyelitis, osteoporosis and tumor) and effective common treatment strategies.
References
More filters
Journal ArticleDOI

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

TL;DR: Osteoclast apoptosis may be a major mechanism whereby bisphosphonates reduce osteoclast numbers and activity, and induction of apoptosis could be a therapeutic goal for new antiosteoclast drugs.
Journal ArticleDOI

Clinical practice. Hypercalcemia associated with cancer.

TL;DR: A 47-year-old woman with a history of breast cancer presents with confusion and dehydration and bone scintigraphy reveals no evidence of skeletal involvement by the tumor.
Journal ArticleDOI

Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials

TL;DR: Zoledronic acid is superior to pamidronate; 4 mg is the dose recommended for initial treatment of HCM and 8 mg for relapsed or refractory hypercalcemia.
Journal ArticleDOI

Denosumab and bisphosphonates: different mechanisms of action and effects.

TL;DR: It is suggested that the key pharmacological differences between denosumab and the bisphosphonates reside in the distribution of the drugs within bone and their effects on precursors and mature osteoclasts, which may explain differences in the degree and rapidity of reduction of bone resorption, their potential differential effects on trabecular and cortical bone, and the reversibility of their actions.
Related Papers (5)